Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...

How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...

Excellence in business comes in many forms. For some companies, it’s a creative use of artificial intelligence to drive growth. For others, it’s a viral marketing campaign or a game-changing invention ...

The AWS SDK for Java enables Java developers to easily work with Amazon Web Services and build scalable solutions with Amazon S3, Amazon DynamoDB, Amazon Glacier, and more. See the AWS SDK for Java ...

Find the latest Recursion Pharmaceuticals, Inc. (RXRX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.

Look closely at this image, stripped of its caption, and join the moderated conversation about what you and other students see. By The Learning Network Look closely at this image, stripped of its ...

Hoosier Democrats, Republicans and insiders talk candidly about issues, the Indiana Statehouse and everything in between on Indiana Week In Review from WFYI Public Media. Join political experts as ...